NDC 65219-668 – Conexxence

Denosumab 60 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC65219-668

Product details

Brand name
Conexxence
Generic name
Denosumab
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761398
Marketed since
June 30, 2025
Listing expires
December 31, 2026
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Conexxence →

Package NDC codes (1)

Package NDCDescriptionSince
65219-668-011 SYRINGE, PLASTIC in 1 CARTON (65219-668-01) / 1 mL in 1 SYRINGE, PLASTICJun 30, 2025